Singh et al EMBO J 2015
Shiv K. Singh(Universitätsmedizin Göttingen), Volker Ellenrieder, Albrecht Neeße(Universitätsklinikum Gießen und Marburg), Jochen Gaedcke(Universitätsmedizin Göttingen), Alexander Koenig, William R. Bamlet(Mayo Clinic), Cornelia Brendel(Philipps University of Marburg), Elisabeth Heßmann(Universitätsmedizin Göttingen), Jin‐San Zhang(Wenzhou Medical University), Thomas C. Smyrk(Mayo Clinic in Arizona), Howard C. Crawford(Henry Ford Health System), Nai‐Ming Chen(University of Göttingen), Marco Merenberger, Thorsten Stiewe(Philipps University of Marburg), Iréne Esposito(Heinrich Heine University Düsseldorf), Jens T. Siveke(German Cancer Research Center), Daniel D. Billadeau(Mayo Clinic), Nadine Voelker(Philipps University of Marburg), Marlen Lahmann(Philipps University of Marburg), Xiaokun Li(Binzhou University), Ansgar Schmidt(Philipps University of Marburg), Matthias Hebrok(University of California, San Francisco), Garima Singh(Central Building Research Institute), Sophia Vogt(Waldkrankenhaus Rudolf Elle)
Unknown
January 1, 2015
Cited by 0
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Esophageal eosinophilia with dysphagia
|Digestive Diseases and Sciences|1993|889
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
|Journal of Cell Science|2001|688